News & Events

Dec 02, 2021

Press Releases

ViaCyte’s Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies

Findings from an international, first-in-human clinical trial show that the ViaCyte stem cell-derived therapy can produce insulin in people with type 1 diabetes Results from the proof-of-concept study reported in Cell Reports Medicine and Cell Stem Cell SAN DIEGO, December 2, 2021 — ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing novel cell […]

Read More
Nov 30, 2021 Press Releases

ViaCyte Appoints Marty Lorenzo as General Counsel

Read More
Nov 16, 2021 Press Releases

CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes

Read More
Oct 20, 2021 Press Releases

ViaCyte to Present at the Jefferies Gene Therapy/Editing Summit

Read More
Oct 19, 2021 Press Releases

ViaCyte to Participate in International Pancreas & Islet Transplantation Association Virtual Congress

Read More
Load More

Media Materials

 

Media Contact

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.